Literature DB >> 13608436

Carcinostatic action of polycarbonyl compounds and their derivatives. IV. Glyoxal bis (thiosemicarbazone) and derivatives.

F A FRENCH, B L FREEDLANDER.   

Abstract

Entities:  

Keywords:  ALDEHYDES/effects; NEOPLASMS/experimental; THIOSEMICARBAZONES/effects

Mesh：

Substances：

Year:  1958        PMID： 13608436

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Cell division, SH, ketoaldehydes, and cancer.

Authors:  L G Együd; A Szent-Györgyi
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

2.  Disulfide-masked iron prochelators: Effects on cell death, proliferation, and hemoglobin production.

Authors:  E A Akam; R D Utterback; J R Marcero; H A Dailey; E Tomat
Journal:  J Inorg Biochem       Date:  2018-01-04       Impact factor: 4.155

Review 3.  New anti-cancer explorations based on metal ions.

Authors:  Han Hu; Qi Xu; Zhimin Mo; Xiaoxi Hu; Qianyuan He; Zhanjie Zhang; Zushun Xu
Journal:  J Nanobiotechnology       Date:  2022-10-23       Impact factor: 9.429

4.  Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.

Authors:  Myrna Hurtado; Umesh T Sankpal; Jaya Chhabra; Deondra T Brown; Rajasekhar Maram; Rafid Patel; Raj K Gurung; Jerry Simecka; Alvin A Holder; Riyaz Basha
Journal:  Invest New Drugs       Date:  2018-05-15       Impact factor: 3.850

5.  Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.

Authors:  Maojin Li; Rouli Zhou; Yi Shan; Li Li; Lin Wang; Gang Liu
Journal:  Oncotarget       Date:  2016-09-06

6.  Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide copper complexes in vivo by bioluminescence imaging.

Authors:  Fang Xie; Huawei Cai; Fangyu Peng
Journal:  J Biol Inorg Chem       Date:  2018-07-13       Impact factor: 3.358

7.  Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.

Authors:  Delphine Denoyer; Helen B Pearson; Sharnel A S Clatworthy; Zoe M Smith; Paul S Francis; Roxana M Llanos; Irene Volitakis; Wayne A Phillips; Peter M Meggyesy; Shashank Masaldan; Michael A Cater
Journal:  Oncotarget       Date:  2016-06-14

8.  Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones).

Authors:  Leonard Howard Damelin; Rupal Jivan; Robin Bruce Veale; Amanda Louise Rousseau; Demetra Mavri-Damelin
Journal:  BMC Cancer       Date:  2014-05-05       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.